Your browser doesn't support javascript.
loading
Anti-complement factor H (CFH) antibodies and a novel CFH gene mutation in an atypical hemolytic uremic syndrome patient with complement activation of the classical pathway.
Minato, Sonoko; Iijima, Hiroyuki; Nakao, Hiro; Nishi, Kentaro; Hidaka, Yoshihiko; Inoue, Norimitsu; Kubota, Mitsuru; Ishiguro, Akira.
  • Minato S; Department of General Pediatrics & Interdisciplinary Medicine, National Center for Child Health and Development (NCCHD), Tokyo, Japan.
  • Iijima H; Center for Postgraduate Education and Training, NCCHD, Tokyo, Japan.
  • Nakao H; Department of General Pediatrics & Interdisciplinary Medicine, National Center for Child Health and Development (NCCHD), Tokyo, Japan.
  • Nishi K; Department of General Pediatrics & Interdisciplinary Medicine, National Center for Child Health and Development (NCCHD), Tokyo, Japan.
  • Hidaka Y; Division of Nephrology and Rheumatology, NCCHD, Tokyo, Japan.
  • Inoue N; Department of Molecular Genetics, Wakayama Medical University, Wakayama, Japan.
  • Kubota M; Department of Molecular Genetics, Wakayama Medical University, Wakayama, Japan.
  • Ishiguro A; Department of General Pediatrics & Interdisciplinary Medicine, National Center for Child Health and Development (NCCHD), Tokyo, Japan.
Immunol Med ; 44(4): 274-277, 2021 Dec.
Article en En | MEDLINE | ID: mdl-33784485

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Síndrome Hemolítico Urémico Atípico Límite: Humans / Infant / Male Idioma: En Año: 2021 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Síndrome Hemolítico Urémico Atípico Límite: Humans / Infant / Male Idioma: En Año: 2021 Tipo del documento: Article